UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036641
Receipt number R000041742
Scientific Title Histologic diagnosis for EUS-guided fine needle aspiration using 22-gauge Acquire Needle in solid lesions
Date of disclosure of the study information 2019/05/03
Last modified on 2019/11/08 12:18:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Histologic diagnosis for EUS-guided fine needle aspiration using 22-gauge Acquire Needle in solid lesions

Acronym

Histologic diagnosis for EUS-guided fine needle aspiration using 22-gauge Acquire Needle in solid lesions

Scientific Title

Histologic diagnosis for EUS-guided fine needle aspiration using 22-gauge Acquire Needle in solid lesions

Scientific Title:Acronym

Histologic diagnosis for EUS-guided fine needle aspiration using 22-gauge Acquire Needle in solid lesions

Region

Japan


Condition

Condition

solid lesion

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine histopathological diagnosis capability of EUS-FNA using a 22-gauge Acquire needle

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The diagnostic accuracy of histology

Key secondary outcomes

The number of passes for diagnosis
Adverse event


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

EUS-FNA is performed on solid tumors three times using a 22G acquire needle.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants were patients with solid masses (>15mm) who were scheduled to undergo EUS-FNA.

Key exclusion criteria

Patients were excluded if they met any of the following criteria: (1) age < 20 years, (2) coagulopathy (international normalized ratio > 1.5 or platelet count < 50,000/mm ), (3) pregnant women, (4) GI obstruction, (5) a European Cooperative Oncology Group performance status of 4.

Target sample size

75


Research contact person

Name of lead principal investigator

1st name Takuji
Middle name
Last name Iwashita

Organization

Gifu University Hospital

Division name

First Dept. of Internal Medicine

Zip code

501-1194

Address

1-1 Yanagido, Gifu 501-1194

TEL

058-230-6308

Email

takuji@w7.dion.ne.jp


Public contact

Name of contact person

1st name Shinya
Middle name
Last name Uemura

Organization

Gifu University Hospital

Division name

First Dept. of Internal Medicine

Zip code

501-1194

Address

1-1 Yanagido, Gifu 501-1194

TEL

058-230-6308

Homepage URL


Email

ueshin550621@gmail.com


Sponsor or person

Institute

Gifu University Hospital, First Dept. of Internal Medicine

Institute

Department

Personal name



Funding Source

Organization

Gifu University Hospital, First Dept. of Internal Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Gifu Municipal Hospital
Tyunou Kousei Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gifu University Hospital Independent Ethics Committee

Address

1-1 Yanagido, Gifu

Tel

058-230-6059

Email

gjme00004@jim.gifu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岐阜大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

75

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 06 Day

Date of IRB

2017 Year 09 Month 06 Day

Anticipated trial start date

2017 Year 09 Month 07 Day

Last follow-up date

2019 Year 09 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2019 Year 11 Month 08 Day


Other

Other related information



Management information

Registered date

2019 Year 05 Month 03 Day

Last modified on

2019 Year 11 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041742


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name